# The Other Breast Matters: Unexpected Pathologies in Oncoplastic Symmetry Procedures

## Authors

- Semra Salimoglu ([ORCID](https://orcid.org/0000-0002-8793-1603)) — Department of General Surgery, University of Health Sciences, İzmir Training and Research Hospital, İzmir, Turkey
- Yuksel Dogan ([ORCID](https://orcid.org/0000-0002-0000-4664)) — Department of General Surgery, Bartın State Hospital, Bartın, Turkey
- Semra Demirli ([ORCID](https://orcid.org/0000-0002-8287-067X)) — Department of General Surgery, Çiğli Kent Hospital, İzmir, Turkey

## Article information

- **Journal:** The Ulutas Medical Journal (Ulutas Med J), ISSN 2149-388X
- **Issue:** Volume 11, Issue 2 (2025), pages 25–33
- **Article type:** Original Article
- **Published online:** 2025-06-25
- **DOI:** [10.5455/umj.20250505094058](https://doi.org/10.5455/umj.20250505094058)
- **Licence:** [CC BY-NC 4.0](https://creativecommons.org/licenses/by-nc/4.0/)
- **Article page:** https://www.ulutasmedicaljournal.com/?mno=256234
- **PDF:** https://www.ulutasmedicaljournal.com/pdf/256234.pdf

## Abstract

Background: Oncoplastic breast surgery allows high-volume excision without compromising aesthetics. We aimed to analyze the probability of identifying high-risk malignant lesions in the contralateral breast. Materials and Methods: The study analyzed patients who underwent oncoplastic surgery between January 2000 and December 2023. All the patients underwent a preoperative assessment of the contralateral breast using mammography, ultrasonography, and breast MRI. Pathology reports were reviewed to identify malignant and high-risk lesions. Results: 38 patients had left-sided breast cancer, and 44 had right-sided breast cancer. The distribution of the pathology results was invasive ductal carcinoma in 68 patients, invasive lobular carcinoma in 11 patients, malignant phylloid tumor in one patient, borderline phylloid tumor, and metaplastic carcinoma in one patient. In contralateral breast pathology, 12 patients had low-risk lesions and 12 patients had high-risk lesions. Two patients had invasive tumors in the contralateral breast. Conclusion: Although detailed preoperative imaging is performed in patients undergoing oncoplastic breast surgery, a significant number of high-risk or malignant lesions may be present in the contralateral breast.

## Keywords

Oncoplastic breast surgery; breast cancer; accidental premalignant; breast-conserving surgery

## How to cite

Salimoglu S, Dogan Y, Demirli S. The Other Breast Matters: Unexpected Pathologies in Oncoplastic Symmetry Procedures. Ulutas Med J. 2025;11(2):25-33. doi:10.5455/umj.20250505094058

## References

1. Fitzal F, Bolliger M, Dunkler D, Geroldinger A, Gambone L, et al. Retrospective, multicenter analysis comparing conventional with oncoplastic breast conserving surgery: oncological and surgical outcomes in women with high-risk breast cancer from the OPBC-01/iTOP2 study. Ann Surg Oncol. 2022;29(3):1061-70. https://doi.org/10.1245/s10434-021-10898-y
2. Macmillan RD, McCulley SJ. Oncoplastic breast surgery: what, when and for whom? Curr Breast Cancer Rep. 2016;8(2):112-7. https://doi.org/10.1007/s12609-016-0212-9
3. Munhoz AM, Montag E, Gemperli R. Oncoplastic breast surgery: indications, techniques and perspectives. Gland Surg. 2013;2(3):143-57.
4. Berry MG, Fitoussi AD, Curnier A, Couturaud B, Salmon RJ. Oncoplastic breast surgery: a review and systematic approach. J Plast Reconstr Aesthet Surg. 2010;63(8): 1233-43. https://doi.org/10.1016/j.bjps.2009.05.006
5. Lokuhetty D, White VA, Watanabe R, Cree IA. WHO classification of tumours of the breast. 5th ed. Lyon (France): IARC Press; 2019.
6. Kuehner G, Darbinian J, Habel L, Axelsson K, Butler S, et al. Benign papillary breast mass lesions: favorable outcomes with surgical excision or imaging surveillance. Ann Surg Oncol. 2019;26(6):1695-703. https://doi.org/10.1245/s10434-019-07180-7
7. Falomo E, Adejumo C, Carson KA, Harvey S, Mullen L, et al. Variability in the management recommendations given for high-risk breast lesions detected on image - guided core needle biopsy at U.S. academic institutions. Curr Probl Diagn Radiol. 2019;48(5):462-6. https://doi.org/10.1067/j.cpradiol.2018.06.004
8. Ramakrishnan R, Bhandare D, Fine N, Khan S, Lal A, et al. Pathologic findings in contralateral reduction mammaplasty specimens in patients with breast cancer. Breast J. 2005;11(5):372-3. Pathologies in Oncoplastic Symmetry Procedures Semra Salimoğlu et al. https://doi.org/10.1111/j.1075-122x.2005.00059.x
9. Iwuchukwu OC, Harvey JR, Dordea M, Critchley AC, Drew PJ. The role of oncoplastic therapeutic mammoplasty in breast cancer surgery: a review. Surg Oncol. 2012;21(2):133-41. https://doi.org/10.1016/j.suronc.2011.01.002
10. Nahabedian MY. History of oncoplastic surgery of the breast. In: Nahabedian MY, editor. Oncoplastic surgery of the breast. Philadelphia (PA): Saunders; 2009. p1-8. https://doi.org/10.1016/b978-0-7020-3181-6.00006-9
11. Piper M, Peled AW, Sbitany H. Oncoplastic breast surgery: current strategies. Gland Surg. 2015;4(2):154-63.
12. Crown A, Handy N, Rocha FG, Grumley JW. Oncoplastic reduction mammaplasty, an effective and safe method of breast conservation. Am J Surg. 2018;215(5):910-5. https://doi.org/10.1016/j.amjsurg.2018.02.024
13. Kusano AS, Trichopoulos D, Terry KL, Chen WY, Willett WC, et al. A prospective study of breast size and premenopausal breast cancer incidence. Int J Cancer. 2006;118(8):2031-4. https://doi.org/10.1002/ijc.21588
14. Schulze AK, Hoskin TL, Moldoveanu D, Sturz JL, Boughey JC. Tumor characteristics of bilateral breast cancer compared with unilateral breast cancer. Ann Surg Oncol. 2024;31(2):947-56. https://doi.org/10.1245/s10434-023-14451-x
15. Eusebi V, Pich A, Macchiorlatti E, Bussolati G. Morpho-functional differentiation in lobular carcinoma of the breast. Histopathology. 1977;1(4):301-14. https://doi.org/10.1111/j.1365-2559.1977.tb01668.x
16. Baelen KV, Geukens T, Maetens M, Tjan-Heijnen V, Lord CJ, et al. Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer. Ann Oncol. 2022;33(8):769-85.
17. Wilson N, Ironside A, Diana A, Oikonomidou O. Lobular breast cancer: a review. Front Oncol. 2020;10: 591399. https://doi.org/10.3389/fonc.2020.591399
18. Visscher DW, Frost MH, Hartmann LC, Frank RD, Vierkant RA, et al. Clinicopathologic features of breast cancers that develop in women with previous benign breast disease. Cancer. 2016;122(3):378-85. https://doi.org/10.1002/cncr.29766
19. Kim H, Park W, Kim SS, Ahn SJ, Kim YB, et al. Prognosis of patients with axillary lymph node metastases from occult breast cancer: analysis of multicenter data. Radiat Oncol J. 2021;39(2):107-12. https://doi.org/10.3857/roj.2021.00241
20. Charfare H, Limongelli S, Purushotham AD. Neo adjuvant chemotherapy in breast cancer. Br J Surg. 2005;92(1):14-23. https://doi.org/10.1002/bjs.4840
21. Liedtke C, Broglio K, Moulder S, Hsu L, Kau SW, et al. Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer. Ann Oncol. 2009;20(12):1953-8. https://doi.org/10.1093/annonc/mdp263
22. Yetkin Dİ, Akpınar MG, Durhan G, Demirkazik FB. Comparison of clinical and magnetic resonance imaging findings of triple-negative breast cancer with non-triple-negative tumours. Pol J Radiol. 2021; 86: 269-76.
23. Masanna YA, Agrawal A, Maraqa L, Fuller M, Down SK, et al. Multifocal and multicentric breast cancer, is it time to think again? Ann R Coll Surg Engl. 2020;102(1):62-6.
24. Ettinger RE, Agarwal S, Izenberg PH, Beil RJ, Sherick DG. Bilateral reduction mammaplasty as an oncoplastic technique for the management of early-stage breast cancer in women with macromastia. Eplasty.2016;16:e 5.
25. Liang Y, Muse-Fisher C, Rambukwella M, Naber SP, Chatterjee A. Malignant and high-risk lesions in the contralateral breast symmetry mastopexy and reduction specimens when performing large-volume displacement oncoplastic surgery. Ann Plast Surg. 2019;82(4 Suppl 3):S185-91. https://doi.org/10.1097/sap.0000000000001910
26. Jackson A, Smith B, Taylor C, et al. Incidental malignancy in contralateral breast following onco-plastic breast-conserving surgery: a retrospective review. Ann Surg Oncol. 2023;30(4):1452-61.
27. Muse-Fisher C, Rambukwella M, Liang Y, Naber S, Chatterjee A. Rates of high risk and malignant lesions incidentally detected in the contralateral breast after large volume displacement oncoplastic breast surgery [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4–8; San Antonio, TX. Cancer Res. 2019;79(4 Suppl):p 22-02. https://doi.org/10.1158/1538-7445.sabcs18-p6-22-02
